| Name | Type | |
|---|
| |
| Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | Comment | |
| |
| Methods of treating hypertriglyceridemia | Comment | |
| |
| Methods of treating hypertriglyceridemia | Expiration Reminder | |
| |
| Process for preparing 2-alkyl-3-halo-6-nitrilpyridine and its carboxylic acid and ester derivatives | Comment | |
| |
| Process for preparing 2-alkyl-3-halo-6-nitrilpyridine and its carboxylic acid and ester derivatives | Expiration Reminder | |
| |
| Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb | Comment | |
| |
| Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorptioin through modulation of nf-kb | Expiration Reminder | |
| |
| Skin compositions containing hydrocortisone | Comment | |
| |
| Skin compositions containing hydrocortisone | Expiration Reminder | |
| |
| Niacin-based pharmaceutical compositions | Comment | |
| |
| Niacin-based pharmaceutical compositions | Expiration Reminder | |
| |
| Treatment of ischemic episodes and cerebroprotection through prostaglandin e2 (pge2) ep2 and/or ep4 receptor agonists | Comment | |
| |
| Treatment of ischemic episodes and cerebroprotection through prostaglandin e2 (pge2) ep2 and/or ep4 receptor agonists | Expiration Reminder | |
| |
| Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Comment | |
| |
| Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Expiration Reminder | |
| |
